Preclinical techniques for drug discovery in psoriasis

Area of Science:

• Dermatology and immunology research.
• Focus on chronic inflammatory skin diseases.

Background:

• Psoriasis is a chronic, inflammatory skin disease driven by the IL-23/Th17 axis.
• Existing treatments offer symptomatic relief but lack curative mechanisms due to unknown disease pathways.
• Drug development for psoriasis requires robust experimental models.

Purpose of the Study:

• To review and analyze in-vivo, in-vitro, and ex-vivo techniques used in psoriasis research.
• To discuss the characteristics, pathological presentations, and mechanisms of these experimental models.
• To highlight the need for improved experimental models that accurately mimic human psoriasis.

Main Methods:

• Review of existing literature on psoriasis experimental models.
• Analysis of various in-vivo, in-vitro, and ex-vivo techniques.
• Discussion of model characteristics, disease mimicry, and limitations.

Main Results:

• Experimental techniques provide valuable data on psoriasis mechanisms and therapeutic targets.
• No current model perfectly imitates human psoriasis in terms of timing, cost, and accuracy.
• Xenotransplantation models show promise in mimicking genetic and immunopathogenic events.
• Imiquimod-induced psoriasis and HaCaT cell lines are popular for their practicality and cost-effectiveness.

Conclusions:

• Advancements in experimental techniques are essential for better psoriasis research and drug development.
• Further improvements are needed to create affordable and accurate models that fully replicate human psoriasis.
• Optimizing experimental models will accelerate the discovery of novel therapeutic strategies for psoriasis.